BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32940334)

  • 1. Scanning window analysis of non-coding regions within normal-tumor whole-genome sequence samples.
    Torcivia JP; Mazumder R
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32940334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human copy number variants are enriched in regions of low mappability.
    Monlong J; Cossette P; Meloche C; Rouleau G; Girard SL; Bourque G
    Nucleic Acids Res; 2018 Aug; 46(14):7236-7249. PubMed ID: 30137632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FABRIC Cancer Portal: A Ranked Catalogue of Gene Selection in Tumors Over the Human Coding Genome.
    Kelman G; Brandes N; Linial M
    Cancer Res; 2021 Feb; 81(4):1178-1185. PubMed ID: 33277365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the coding genome: non-coding mutations and cancer.
    Walavalkar K; Notani D
    Front Biosci (Landmark Ed); 2020 Jun; 25(10):1828-1838. PubMed ID: 32472759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant detection sensitivity and biases in whole genome and exome sequencing.
    Meynert AM; Ansari M; FitzPatrick DR; Taylor MS
    BMC Bioinformatics; 2014 Jul; 15(1):247. PubMed ID: 25038816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pan-cancer landscape of somatic mutations in non-unique regions of the human genome.
    Tarabichi M; Demeulemeester J; Verfaillie A; Flanagan AM; Van Loo P; Konopka T
    Nat Biotechnol; 2021 Dec; 39(12):1589-1596. PubMed ID: 34282324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the function of genetic variants in the non-coding genomic regions: approaches for identifying human regulatory variants affecting gene expression.
    Li MJ; Yan B; Sham PC; Wang J
    Brief Bioinform; 2015 May; 16(3):393-412. PubMed ID: 24916300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
    Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
    BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer regulatory variation.
    Hennessey RC; Brown KM
    Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data.
    Abécassis J; Reyal F; Vert JP
    Nat Commun; 2021 Sep; 12(1):5352. PubMed ID: 34504064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
    Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
    Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Framework for quality assessment of whole genome cancer sequences.
    Whalley JP; Buchhalter I; Rheinbay E; Raine KM; Stobbe MD; Kleinheinz K; Werner J; Beltran S; Gut M; Hübschmann D; Hutter B; Livitz D; Perry MD; Rosenberg M; Saksena G; Trotta JR; Eils R; Gerhard DS; Campbell PJ; Schlesner M; Gut IG
    Nat Commun; 2020 Oct; 11(1):5040. PubMed ID: 33028839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNCDatabase: a database of non-coding cancer drivers.
    Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
    Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep sequencing of 10,000 human genomes.
    Telenti A; Pierce LC; Biggs WH; di Iulio J; Wong EH; Fabani MM; Kirkness EF; Moustafa A; Shah N; Xie C; Brewerton SC; Bulsara N; Garner C; Metzker G; Sandoval E; Perkins BA; Och FJ; Turpaz Y; Venter JC
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11901-11906. PubMed ID: 27702888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long, abundantly expressed non-coding transcripts are altered in cancer.
    Perez DS; Hoage TR; Pritchett JR; Ducharme-Smith AL; Halling ML; Ganapathiraju SC; Streng PS; Smith DI
    Hum Mol Genet; 2008 Mar; 17(5):642-55. PubMed ID: 18006640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplatform discovery and regulatory function analysis of structural variations in non-small cell lung carcinoma.
    Xia L; Wang Z; Wu X; Zeng T; Luo W; Hu X; Ni Y; Che G; Liu L; Zhang W; Xie D; Li W
    Cell Rep; 2021 Sep; 36(10):109660. PubMed ID: 34496260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome sequencing analysis for cancer genomics and precision medicine.
    Nakagawa H; Fujita M
    Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional analysis of somatic coding and UTR indels in breast and lung cancer genomes.
    Chen J; Guo JT
    Sci Rep; 2021 Oct; 11(1):21178. PubMed ID: 34707120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.